840062C

16:0-22:6 PS

1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phospho-L-serine (sodium salt), chloroform

• 동의어(들): 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-L-serine (sodium salt); PS(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
• 실험식(Hill 표기법): C₄₄H₇₃NO₁₀PNa
• CAS Number: 474943-17-4
• Molecular Weight: 830.01
• UNSPSC 코드: 51191904
• NACRES: NA.25

속성

• 분석: >99% (TLC)
• 양식: liquid
• 포장: pkg of 1 × 2.5 mL (840062C-25mg)
• 제조업체/상표: Avanti Research^™ - A Croda Brand 840062C
• 농도: 10 mg/mL (840062C-25mg)
• 지질 유형: phospholipids; cardiolipins
• 배송 상태: dry ice
• 저장 온도: −20°C
• SMILES string: [H][C@@](COP([O-])(OC[C@](C([O-])=O)([H])[NH3+])=O)(OC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O)COC(CCCCCCCCCCCCCCC)=O.[Na+]
• InChI: 1S/C44H74NO10P.Na/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-24-26-28-30-32-34-36-43(47)55-40(38-53-56(50,51)54-39-41(45)44(48)49)37-52-42(46)35-33-31-29-27-25-23-16-14-12-10-8-6-4-2;/h5,7,11,13,17-18,20-21,24,26,30,32,40-41H,3-4,6,8-10,12,14-16,19,22-23,25,27-29,31,33-39,45H2,1-2H3,(H,48,49)(H,50,51);/q;+1/p-1/b7-5-,13-11-,18-17-,21-20-,26-24-,32-30-;/t40-,41+;/m1./s1
• InChI key: LONMFPKAKXIJFJ-ROYAEOKWSA-M

설명

일반 설명

16:0-22:6 PS or 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phospho-L-serine is a glycerophospholipid having, palmitic acid and docosahexaenic acid attached to the sn-1 and sn-2 positions of the glycerol backbone. The phospholipid in this compound is phosphoserine, a negatively charged lipid.

애플리케이션

16:0-22:6 PS or 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phospho-L-serine (sodium salt) has been used as a calibration standard for lipidomic analysis.

포장

5 mL Clear Glass Sealed Ampule (840062C-25mg)

법적 정보

Avanti Research is a trademark of Avanti Polar Lipids, LLC

안전성 정보

• 픽토그램: GHS06,GHS08
• 신호어: Danger
• 유해 및 위험 성명서: H302,H315,H319,H331,H336,H351,H361d,H372
• 예방조치 성명서: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• Hazard Classifications: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• 표적 기관: Central nervous system
• WGK: WGK 3